BridgeBio Oncology Therapeutics, Inc.
BBOTNasdaqCIK 1869105HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $m | not reported | not reported | 17.9Research and development, Q3 FY2024, three months to 2024-09-30$17.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | 19.5Research and development, Q4 FY2024, three months to 2024-12-31$19.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-094112. Derived: 12-month figure less the 9-month figure.Report this figure | 20.6Research and development, Q1 FY2025, three months to 2025-03-31$20.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | 27.4Research and development, Q2 FY2025, three months to 2025-06-30$27.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | 35.1Research and development, Q3 FY2025, three months to 2025-09-30$35.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | 38.1Research and development, Q4 FY2025, three months to 2025-12-31$38.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-094112. Derived: 12-month figure less the 9-month figure.Report this figure | 39.8Research and development, Q1 FY2026, three months to 2026-03-31$39.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | 49.2Research and development, Q2 FY2026, three months to 2026-06-30$49.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure |
| Operating income | $m | (0.1)Operating income, Q1 FY2024, three months to 2024-03-31−$66.7k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001213900-25-044424.Report this figure | (0.2)Operating income, Q2 FY2024, three months to 2024-06-30−$152.3k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-01, accession 0001213900-25-070659.Report this figure | (19.7)Operating income, Q3 FY2024, three months to 2024-09-30−$19.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | (21.9)Operating income, Q4 FY2024, three months to 2024-12-31−$21.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-094112. Derived: 12-month figure less the 9-month figure.Report this figure | (23.1)Operating income, Q1 FY2025, three months to 2025-03-31−$23.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | (30.1)Operating income, Q2 FY2025, three months to 2025-06-30−$30.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | (49.2)Operating income, Q3 FY2025, three months to 2025-09-30−$49.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | (43.4)Operating income, Q4 FY2025, three months to 2025-12-31−$43.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-094112. Derived: 12-month figure less the 9-month figure.Report this figure | (46.2)Operating income, Q1 FY2026, three months to 2026-03-31−$46.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | (60.2)Operating income, Q2 FY2026, three months to 2026-06-30−$60.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure |
| Income tax | $m | not reported | not reported | 0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | 0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-094112. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0001213900-25-044424.Report this figure | 0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | 0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | 0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-094112. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | 0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure |
| Net income | $m | (15.4)Net income, Q1 FY2024, three months to 2024-03-31−$15.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | (21.8)Net income, Q2 FY2024, three months to 2024-06-30−$21.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | (17.3)Net income, Q3 FY2024, three months to 2024-09-30−$17.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | (19.7)Net income, Q4 FY2024, three months to 2024-12-31−$19.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-094112. Derived: 12-month figure less the 9-month figure.Report this figure | (22.1)Net income, Q1 FY2025, three months to 2025-03-31−$22.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | (28.4)Net income, Q2 FY2025, three months to 2025-06-30−$28.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | (44.8)Net income, Q3 FY2025, three months to 2025-09-30−$44.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | (38.8)Net income, Q4 FY2025, three months to 2025-12-31−$38.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-094112. Derived: 12-month figure less the 9-month figure.Report this figure | (42.1)Net income, Q1 FY2026, three months to 2026-03-31−$42.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | (56.5)Net income, Q2 FY2026, three months to 2026-06-30−$56.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure |
| Diluted EPS | $ per share | not reported | not reported | (1562.18)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1562.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | not reported | (54.23)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$54.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | (566.46)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$566.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | (1.03)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | not reported | (526.11)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$526.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | (705.20)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$705.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure |
| Basic EPS | $ per share | not reported | not reported | (1562.18)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1562.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | not reported | (54.23)Basic EPS, Q1 FY2025, three months to 2025-03-31−$54.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | (566.46)Basic EPS, Q2 FY2025, three months to 2025-06-30−$566.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | (1.03)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | not reported | (526.11)Basic EPS, Q1 FY2026, three months to 2026-03-31−$526.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | (705.20)Basic EPS, Q2 FY2026, three months to 2026-06-30−$705.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure |
Balance sheet
| Line item | Unit | period not labelled2023-09-30 | period not labelled2023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | not reported | 0.0Cash and equivalents, period not labelled, at 2023-12-31$0. XBRL concept us-gaap:Cash. 10-K filed 2025-03-11, accession 0001213900-25-022387.Report this figure | 1.8Cash and equivalents, Q1 FY2024, at 2024-03-31$1.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001213900-24-043582.Report this figure | 1.8Cash and equivalents, Q2 FY2024, at 2024-06-30$1.8m. XBRL concept us-gaap:Cash. 10-Q filed 2024-08-14, accession 0001213900-24-068630.Report this figure | 1.8Cash and equivalents, Q3 FY2024, at 2024-09-30$1.8m. XBRL concept us-gaap:Cash. 10-Q filed 2024-11-14, accession 0001213900-24-098483.Report this figure | 30.9Cash and equivalents, FY2024, at 2024-12-31$30.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001193125-26-094112.Report this figure | 1.0Cash and equivalents, Q1 FY2025, at 2025-03-31$963.1k. XBRL concept us-gaap:Cash. 10-Q filed 2025-05-15, accession 0001213900-25-044424.Report this figure | 0.7Cash and equivalents, Q2 FY2025, at 2025-06-30$664.2k. XBRL concept us-gaap:Cash. 10-Q filed 2025-08-01, accession 0001213900-25-070659.Report this figure | 409Cash and equivalents, Q3 FY2025, at 2025-09-30$408.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | 374Cash and equivalents, FY2025, at 2025-12-31$373.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | 52.7Cash and equivalents, Q1 FY2026, at 2026-03-31$52.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | 54.1Cash and equivalents, Q2 FY2026, at 2026-06-30$54.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure |
| Current assets | $m | not reported | not reported | 2.1Current assets, Q1 FY2024, at 2024-03-31$2.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001213900-24-043582.Report this figure | 2.1Current assets, Q2 FY2024, at 2024-06-30$2.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001213900-24-068630.Report this figure | 2.0Current assets, Q3 FY2024, at 2024-09-30$2.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001213900-24-098483.Report this figure | 159Current assets, FY2024, at 2024-12-31$158.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001193125-26-094112.Report this figure | 1.2Current assets, Q1 FY2025, at 2025-03-31$1.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001213900-25-044424.Report this figure | 0.9Current assets, Q2 FY2025, at 2025-06-30$876.8k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-01, accession 0001213900-25-070659.Report this figure | 476Current assets, Q3 FY2025, at 2025-09-30$476.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | 432Current assets, FY2025, at 2025-12-31$432.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | 267Current assets, Q1 FY2026, at 2026-03-31$266.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | 242Current assets, Q2 FY2026, at 2026-06-30$242.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure |
| Total assets | $m | not reported | 0.3Total assets, period not labelled, at 2023-12-31$332.9k. XBRL concept us-gaap:Assets. 10-K filed 2025-03-11, accession 0001213900-25-022387.Report this figure | 188Total assets, Q1 FY2024, at 2024-03-31$187.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001213900-24-043582.Report this figure | 190Total assets, Q2 FY2024, at 2024-06-30$189.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001213900-24-068630.Report this figure | 192Total assets, Q3 FY2024, at 2024-09-30$192.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001213900-24-098483.Report this figure | 164Total assets, FY2024, at 2024-12-31$164.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001193125-26-094112.Report this figure | 196Total assets, Q1 FY2025, at 2025-03-31$195.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001213900-25-044424.Report this figure | 197Total assets, Q2 FY2025, at 2025-06-30$197.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-01, accession 0001213900-25-070659.Report this figure | 485Total assets, Q3 FY2025, at 2025-09-30$484.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | 448Total assets, FY2025, at 2025-12-31$448.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | 418Total assets, Q1 FY2026, at 2026-03-31$417.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | 377Total assets, Q2 FY2026, at 2026-06-30$376.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure |
| Current liabilities | $m | not reported | 0.4Current liabilities, period not labelled, at 2023-12-31$396.5k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-11, accession 0001213900-25-022387.Report this figure | 0.0Current liabilities, Q1 FY2024, at 2024-03-31$23.3k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001213900-24-043582.Report this figure | 0.1Current liabilities, Q2 FY2024, at 2024-06-30$79.1k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001213900-24-068630.Report this figure | 0.1Current liabilities, Q3 FY2024, at 2024-09-30$126.7k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001213900-24-098483.Report this figure | 19.6Current liabilities, FY2024, at 2024-12-31$19.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001193125-26-094112.Report this figure | 1.9Current liabilities, Q1 FY2025, at 2025-03-31$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001213900-25-044424.Report this figure | 2.6Current liabilities, Q2 FY2025, at 2025-06-30$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-01, accession 0001213900-25-070659.Report this figure | 35.7Current liabilities, Q3 FY2025, at 2025-09-30$35.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | 35.0Current liabilities, FY2025, at 2025-12-31$35.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | 43.3Current liabilities, Q1 FY2026, at 2026-03-31$43.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | 51.6Current liabilities, Q2 FY2026, at 2026-06-30$51.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure |
| Total liabilities | $m | not reported | 0.4Total liabilities, period not labelled, at 2023-12-31$396.5k. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-11, accession 0001213900-25-022387.Report this figure | 5.5Total liabilities, Q1 FY2024, at 2024-03-31$5.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001213900-24-043582.Report this figure | 5.6Total liabilities, Q2 FY2024, at 2024-06-30$5.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001213900-24-068630.Report this figure | 5.6Total liabilities, Q3 FY2024, at 2024-09-30$5.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001213900-24-098483.Report this figure | 19.6Total liabilities, FY2024, at 2024-12-31$19.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001193125-26-094112.Report this figure | 7.4Total liabilities, Q1 FY2025, at 2025-03-31$7.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001213900-25-044424.Report this figure | 8.1Total liabilities, Q2 FY2025, at 2025-06-30$8.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-01, accession 0001213900-25-070659.Report this figure | 38.1Total liabilities, Q3 FY2025, at 2025-09-30$38.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | 37.3Total liabilities, FY2025, at 2025-12-31$37.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | 45.4Total liabilities, Q1 FY2026, at 2026-03-31$45.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | 53.6Total liabilities, Q2 FY2026, at 2026-06-30$53.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure |
| Shareholders' equity | $m | (0.0)Shareholders' equity, period not labelled, at 2023-09-30−$21.9k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001213900-24-098483.Report this figure | (116)Shareholders' equity, period not labelled, at 2023-12-31−$115.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001193125-26-094112.Report this figure | (129)Shareholders' equity, Q1 FY2024, at 2024-03-31−$128.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | (143)Shareholders' equity, Q2 FY2024, at 2024-06-30−$143.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | (159)Shareholders' equity, Q3 FY2024, at 2024-09-30−$159.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | (179)Shareholders' equity, FY2024, at 2024-12-31−$178.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | (200)Shareholders' equity, Q1 FY2025, at 2025-03-31−$200.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | (228)Shareholders' equity, Q2 FY2025, at 2025-06-30−$227.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | 447Shareholders' equity, Q3 FY2025, at 2025-09-30$446.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277834.Report this figure | 411Shareholders' equity, FY2025, at 2025-12-31$411.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | 372Shareholders' equity, Q1 FY2026, at 2026-03-31$372.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure | 323Shareholders' equity, Q2 FY2026, at 2026-06-30$323.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344661.Report this figure |
Cash flow
| Line item | Unit | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $m | (0.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$618.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001213900-25-044424.Report this figure | (0.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$29.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-01, accession 0001213900-25-070659. Derived: 6-month figure less the 3-month figure.Report this figure | (39.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$39.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277834. Derived: 9-month figure less the 6-month figure.Report this figure | (15.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$15.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-094112. Derived: 12-month figure less the 9-month figure.Report this figure | (19.6)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$19.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | (23.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$23.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344661. Derived: 6-month figure less the 3-month figure.Report this figure | (28.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$28.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277834. Derived: 9-month figure less the 6-month figure.Report this figure | (42.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$42.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-094112. Derived: 12-month figure less the 9-month figure.Report this figure | (35.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$35.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | (44.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$44.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344661. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $m | not reported | not reported | not reported | 0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-094112. Derived: 12-month figure less the 9-month figure.Report this figure | 0.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$162.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | 0.2Capital expenditure, Q2 FY2025, three months to 2025-06-30$231.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-344661. Derived: 6-month figure less the 3-month figure.Report this figure | 0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$140.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-277834. Derived: 9-month figure less the 6-month figure.Report this figure | 0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$73.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-094112. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$24.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219829.Report this figure | 0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$47.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-344661. Derived: 6-month figure less the 3-month figure.Report this figure |
Shares
| Line item | Unit | Q3 FY20242024-09-30 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 0.0 | 0.4 | 50.2 | 43.5 | 0.1 | 80.1 |
Shares outstanding: 80.17m at Aug 6, 2026, from the cover of the 10-Q filed Aug 11, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.